01 2Alcon Canada Inc.
02 2Gowling WLG (Canada) LLP
01 22167524
02 12586807
03 12781254
01 4Nepafenac
01 2Suspension
02 2suspension
01 22015-06-06
02 12025-12-02
03 12030-12-01
Patent Expiration Date : 2015-06-06
Date Granted : 2002-08-13
Brand Name : NEVANAC
Patent Number : 2167524
Filing Date : 1995-06-06
Strength per Unit : 0.1% (w / v)
Dosage Form : suspension
Human Or VET : Human
Route of Administration : ophthalmic
Patent Expiration Date : 2015-06-06
Date Granted : 2002-08-13
Patent Expiration Date : 2015-06-06
Date Granted : 2002-08-13
Brand Name : ILEVRO
Patent Number : 2167524
Filing Date : 1995-06-06
Strength per Unit : 0.3% (w / v)
Dosage Form : Suspension
Human Or VET : Human
Route of Administration : Ophthalmic
Patent Expiration Date : 2015-06-06
Date Granted : 2002-08-13
Patent Expiration Date : 2025-12-02
Date Granted : 2013-01-29
Brand Name : NEVANAC
Patent Number : 2586807
Filing Date : 2005-12-02
Strength per Unit : 0.1% (w / v)
Dosage Form : suspension
Human Or VET : Human
Route of Administration : ophthalmic
Patent Expiration Date : 2025-12-02
Date Granted : 2013-01-29
Patent Expiration Date : 2030-12-01
Date Granted : 2016-06-28
Brand Name : ILEVRO
Patent Number : 2781254
Filing Date : 2010-12-01
Strength per Unit : 0.3% (w / v)
Dosage Form : Suspension
Human Or VET : Human
Route of Administration : Ophthalmic
Patent Expiration Date : 2030-12-01
Date Granted : 2016-06-28
LOOKING FOR A SUPPLIER?
